Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 80
Filter
Add more filters

Publication year range
1.
Anal Chem ; 92(13): 8722-8731, 2020 07 07.
Article in English | MEDLINE | ID: mdl-32285664

ABSTRACT

Worldwide, multiresistant bacterial strains are emerging at unprecedented rates. This development seriously threatens the ability of humanity to treat even common infections, resulting in disability and death. Furthermore, this development endangers all medical achievements including cancer therapy or organ transplantations. Therefore, the World Health Organization has endorsed antimicrobial resistance as a great threat to humanity. To still allow effective treatment of patients, rapid, automated, and reliable antibiotic susceptibility testing (AST) of bacterial pathogens is essential. Thereby, speed and sensitivity of the AST results are crucial for improving patient care. Here, Raman spectroscopy as a nondestructive technique providing chemical-specific information is employed to monitor the deuterium uptake of metabolically active bacteria during antibiotic treatment, enabling fast and reliable AST. For this purpose, a bulk sample-preparation method was developed, allowing a high-throughput analysis of a significant number of cells. A protocol was developed for Gram-positive (Enterococcus faecalis) and Gram-negative (Escherichia coli) reference strains and was tested on 51 clinical isolates with well-characterized resistance phenotypes against ampicillin, ciprofloxacin, meropenem, and vancomycin. Borderline resistant and heteroresistant phenotypes were observed and further investigated. This is of critical importance as the sensitive detection of low-frequency heteroresistance in bacterial populations is a huge challenge. Such isolates seem susceptible but are resistant to treatment in vivo. Automatable analysis detects strong phenotypes within 3 h. On the basis of experimental and modeled data, heteroresistance is estimated to be detectable down to frequencies of 10-6 and investigated on clinical isolates as a proof-of-concept study, but requiring longer incubation time.


Subject(s)
Drug Resistance, Bacterial , Microbial Sensitivity Tests/methods , Spectrum Analysis, Raman , Anti-Bacterial Agents/pharmacology , Deuterium/chemistry , Deuterium/metabolism , Enterococcus faecalis/drug effects , Enterococcus faecalis/isolation & purification , Escherichia coli/drug effects , Escherichia coli/isolation & purification , Humans
2.
Sci Rep ; 12(1): 707, 2022 Jan 13.
Article in English | MEDLINE | ID: mdl-35027601

ABSTRACT

This work presents a multisensor hyperspectral approach for the characterization of ultramarine blue, a valuable historical pigment, at the microscopic scale combining the information of four analytical techniques at the elemental and molecular levels. The hyperspectral images collected were combined in a single hypercube, where the pixels of the various spectral components are aligned on top of each other. Selected spectral descriptors have been defined to reduce data dimensionality before applying unsupervised chemometric data analysis approaches. Lazurite, responsible for the blue color of the pigment, was detected as the major mineral phase present in synthetic and good quality pigments. Impurities like pyrite were detected in lower quality samples, although the clear identification of other mineral phases with silicate basis was more difficult. There is no correlation between the spatial distribution of the bands arising in the Raman spectra of natural samples in the region 1200-1850 cm-1 and any of the transition metals or rare earth elements (REE). With this information, the previous hypothesis (based on bulk analysis) attributing these bands to luminescence emissions due to impurities of these elements must be revised. We propose the consideration of CO2 molecules trapped in the cages of the aluminosilicate structure of sodalite-type. Additionally, correlation between certain Raman features and the combined presence of Ca, P, and REE, in particular Nd, was detected for the lowest quality pigment. Our results highlight the usefulness of fusing chemical images obtained via different imaging techniques to obtain relevant information on chemical structure and properties.

3.
Brain ; 133(Pt 3): 701-12, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20207700

ABSTRACT

Neurodegeneration with brain iron accumulation encompasses a heterogeneous group of rare neurodegenerative disorders that are characterized by iron accumulation in the brain. Severe generalized dystonia is frequently a prominent symptom and can be very disabling, causing gait impairment, difficulty with speech and swallowing, pain and respiratory distress. Several case reports and one case series have been published concerning therapeutic outcome of pallidal deep brain stimulation in dystonia caused by neurodegeneration with brain iron degeneration, reporting mostly favourable outcomes. However, with case studies, there may be a reporting bias towards favourable outcome. Thus, we undertook this multi-centre retrospective study to gather worldwide experiences with bilateral pallidal deep brain stimulation in patients with neurodegeneration with brain iron accumulation. A total of 16 centres contributed 23 patients with confirmed neurodegeneration with brain iron accumulation and bilateral pallidal deep brain stimulation. Patient details including gender, age at onset, age at operation, genetic status, magnetic resonance imaging status, history and clinical findings were requested. Data on severity of dystonia (Burke Fahn Marsden Dystonia Rating Scale-Motor Scale, Barry Albright Dystonia Scale), disability (Burke Fahn Marsden Dystonia Rating Scale-Disability Scale), quality of life (subjective global rating from 1 to 10 obtained retrospectively from patient and caregiver) as well as data on supportive therapy, concurrent pharmacotherapy, stimulation settings, adverse events and side effects were collected. Data were collected once preoperatively and at 2-6 and 9-15 months postoperatively. The primary outcome measure was change in severity of dystonia. The mean improvement in severity of dystonia was 28.5% at 2-6 months and 25.7% at 9-15 months. At 9-15 months postoperatively, 66.7% of patients showed an improvement of 20% or more in severity of dystonia, and 31.3% showed an improvement of 20% or more in disability. Global quality of life ratings showed a median improvement of 83.3% at 9-15 months. Severity of dystonia preoperatively and disease duration predicted improvement in severity of dystonia at 2-6 months; this failed to reach significance at 9-15 months. The study confirms that dystonia in neurodegeneration with brain iron accumulation improves with bilateral pallidal deep brain stimulation, although this improvement is not as great as the benefit reported in patients with primary generalized dystonias or some other secondary dystonias. The patients with more severe dystonia seem to benefit more. A well-controlled, multi-centre prospective study is necessary to enable evidence-based therapeutic decisions and better predict therapeutic outcomes.


Subject(s)
Brain Diseases/therapy , Brain/physiopathology , Deep Brain Stimulation/methods , Dystonia/therapy , Iron/metabolism , Neurodegenerative Diseases/therapy , Adolescent , Adult , Brain Diseases/physiopathology , Child , Child, Preschool , Deep Brain Stimulation/adverse effects , Dystonia/physiopathology , Female , Functional Laterality , Globus Pallidus/physiopathology , Humans , Infant , Male , Neurodegenerative Diseases/physiopathology , Retrospective Studies , Treatment Outcome , Young Adult
4.
Solid State Commun ; 146(1-2): 1-6, 2008 Apr 01.
Article in English | MEDLINE | ID: mdl-20539828

ABSTRACT

Extraordinary optoconductance (EOC) devices with symmetric leads have been shown to have a symmetric positional dependence when exposed to focused illumination. While advantageous for a position sensitive detector (PSD), this symmetric positional dependence, when the device is uniformly illuminated, leads to a minimization of the output voltage. Here, with the aid of a previously employed point charge model, we address two ways to break the symmetry and recover the output signal. The first is to impose uniform illumination but only on half the sample. This method has practical limitations as the device is miniaturized to the nanoscale. The second is via asymmetric placement of the voltage probes in a four-probe measurement. Crucial to the discussion is the effect of the surface charge density. Several ways of modeling the induced surface charge density are presented. Utilizing the above described approach, optimal asymmetric lead positions are found.

5.
Gene ; 158(1): 91-6, 1995 May 26.
Article in English | MEDLINE | ID: mdl-7789818

ABSTRACT

We describe a series of plasmid vectors for DNA cloning in staphylococci. pPS11 is a promoter probe plasmid containing a promoterless lipase (Lip)-encoding gene (lip). Insertion of a promoter-bearing DNA fragment at the single BamHI site turns on lip expression. Lip activity can be easily determined to estimate the strength of the inserted promoter. pPS11 served also as a basis for the construction of vectors which allow xylose-inducible gene expression in Staphylococcus carnosus (Sc). Using plasmid pCX15, we studied xylose-inducible lip expression in Sc. The lip expression is under transcriptional control of the repressor, XylR. The xylR gene, the XylR target sequence and the xylA promoter/operator sequence with the cis-acting catabolite-responsive element (cre) are derived from the xyl operon of S. xylosus. The single BamHI site in front of the lip ribosome-binding site (RBS) also makes it possible to put other promoterless genes under transcriptional control of XylR. To facilitate the controlled expression of genes which merely start with the start codon and have no RBS, or to insert genes with their own RBS, pCX26 and pCX26 delta lip were constructed. The influence of xylose and glucose on lip expression was studied both in a batch culture and in a fermentor under controlled pH conditions. With pCX15, the presence of xylose led to a 40-fold increase in extracellular Lip activity, while the presence of glucose caused a repression of lip expression. The results suggest that the xylA promoter is subject to two different regulatory mechanisms, one of which involves the repression of the xylA promoter by XylR in the absence of xylose, and the other involves a glucose-mediated catabolite repression which dominates over the xylose induction.


Subject(s)
Glucose/pharmacology , Plasmids , Promoter Regions, Genetic , Staphylococcus/genetics , Xylose/pharmacology , Base Sequence , DNA Primers , Gene Expression Regulation, Bacterial/drug effects , Gene Expression Regulation, Enzymologic/drug effects , Lipase/genetics , Molecular Sequence Data , Xylose/genetics
6.
J Med Chem ; 44(11): 1666-74, 2001 May 24.
Article in English | MEDLINE | ID: mdl-11356102

ABSTRACT

New molecular modeling tools were developed to construct a qualitative pharmacophore model for histamine H3 receptor antagonists. The program SLATE superposes ligands assuming optimum hydrogen bond geometry. One or two ligands are allowed to flex in the procedure, thereby enabling the determination of the bioactive conformation of flexible H3 antagonists. In the derived model, four hydrogen-bonding site points and two hydrophobic pockets available for binding antagonists are revealed. The model results in a better understanding of the structure-activity relationships of H3 antagonists. To validate the model, a series of new antagonists was synthesized. The compounds were designed to interact with all four hydrogen-bonding site points and the two hydrophobic pockets simultaneously. These ligands have high H3 receptor affinity, thereby illustrating how the model can be used in the design of new classes of H3 antagonists.


Subject(s)
Histamine Antagonists/chemistry , Receptors, Histamine H3/drug effects , Animals , Benzyl Compounds/chemical synthesis , Benzyl Compounds/chemistry , Benzyl Compounds/metabolism , Benzyl Compounds/pharmacology , Cerebral Cortex/metabolism , Guinea Pigs , Histamine Antagonists/chemical synthesis , Histamine Antagonists/metabolism , Histamine Antagonists/pharmacology , Histamine Release/drug effects , Imidazoles/chemical synthesis , Imidazoles/chemistry , Imidazoles/metabolism , Imidazoles/pharmacology , In Vitro Techniques , Intestines/drug effects , Intestines/physiology , Ligands , Models, Molecular , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Muscle, Smooth/physiology , Piperidines/chemical synthesis , Piperidines/chemistry , Piperidines/metabolism , Piperidines/pharmacology , Quantitative Structure-Activity Relationship , Radioligand Assay , Rats , Receptors, Histamine H3/metabolism , Software
7.
Eur J Pharmacol ; 387(1): R5-7, 2000 Jan 03.
Article in English | MEDLINE | ID: mdl-10633171

ABSTRACT

Transient expression of the wild-type human histamine H(1) receptor in SV40-immortalised African green monkey kidney cells resulted in an agonist-independent elevation of the basal levels of the second messenger inositoltrisphospate. Several histamine H(1) receptor antagonists, including the therapeutically used anti-allergics cetirizine, loratadine and epinastine reduced this constitutive histamine H(1) receptor activity. Inverse agonism, i.e., stabilisation of an inactive conformation of the human histamine H(1) receptor, may therefore be a key component of the anti-allergic mechanism of action of clinically used antihistamines.


Subject(s)
Histamine Agonists/pharmacology , Histamine H1 Antagonists/pharmacology , Receptors, Histamine H1/drug effects , Animals , Binding, Competitive , COS Cells , Cell Line, Transformed , Histamine/pharmacology , Histamine Agonists/metabolism , Histamine H1 Antagonists/metabolism , Humans , Inositol Phosphates/metabolism , Methylhistidines/pharmacology , Pyrilamine/metabolism , Pyrilamine/pharmacology , Radioligand Assay , Receptors, Histamine H1/genetics , Receptors, Histamine H1/metabolism , Recombinant Fusion Proteins/drug effects , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
8.
Blood Coagul Fibrinolysis ; 5(1): 59-62, 1994 Feb.
Article in English | MEDLINE | ID: mdl-8180339

ABSTRACT

Heterozygous factor XI deficiency occurs very frequently among Ashkenazi Jews. To investigate the potential influence of a co-inherited factor XI deficiency state on the clinical phenotype of mild/moderate haemophilia A, 28 unrelated haemophiliacs of Jewish origin were screened for the two most common factor XI gene mutations. Gene lesions were identified in two out of 14 patients of Ashkenazi origin. In the one family analysed further, co-inheritance of both factor XI and factor VIII deficiencies was associated with a bleeding tendency that was more severe than that associated with either deficiency alone.


Subject(s)
Factor XI Deficiency/complications , Hemophilia A/complications , Hemophilia A/genetics , Jews , Base Sequence , Deoxyribonucleases, Type II Site-Specific , Molecular Sequence Data , Mutation , Phenotype , Polymerase Chain Reaction
9.
BMC Ecol ; 1: 4, 2001.
Article in English | MEDLINE | ID: mdl-11737879

ABSTRACT

BACKGROUND: Changes in the survival-rate during the larval phase may strongly influence the recruitment level in marine fish species. During the larval phase different 'critical periods' are discussed, e.g. the hatching period and the first-feeding period. No such information was available for the Baltic cod stock, a commercially important stock showing reproduction failure during the last years. We calculated field-based mortality rates for larval Baltic cod during these phases using basin-wide abundance estimates from two consecutive surveys. Survey information was corrected by three dimensional hydrodynamic model runs. RESULTS: The corrections applied for transport were of variable impact, depending on the prevailing circulation patterns. Especially at high wind forcing scenarios, abundance estimates have the potential to be biased without accounting for transport processes. In May 1988 mortality between hatch and first feeding amounted to approximately 20% per day. Mortality rates during the onset of feeding were considerably lower with only 7% per day. In August 1991 the situation was vice versa: Extremely low mortality rates of 0.08% per day were calculated between hatch and first feeding, while the period between the onset of feeding to the state of an established feeder was more critical with mortality rates of 22% per day. CONCLUSIONS: Mortality rates during the different proposed 'critical periods' were found to be highly variable. Survival rates of Baltic cod are not only influenced by a single 'critical period', but can be limited at different points during the larval phase, depending on several biotic and abiotic factors.


Subject(s)
Fishes/physiology , Models, Biological , Mortality , Animals , Fishes/growth & development , Larva/growth & development , Larva/physiology , Seawater/chemistry , Time Factors , Water Movements , Zygote/physiology
10.
Disabil Rehabil ; 18(8): 429-38, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8842628

ABSTRACT

This paper reviews the occupational integration of employees with disabilities in Germany. A short sketch of historical trends is followed by a presentation of the current tasks and goals of rehabilitation, as well as the legal and institutional framing conditions for the integration and reintegration of people with disabilities into the work process. It is shown that one important guarantee for the success of integration is an ergonomic workplace design that takes the needs of employees with disabilities into account.


Subject(s)
Disabled Persons/rehabilitation , Ergonomics , Disabled Persons/legislation & jurisprudence , Germany , Humans , Rehabilitation, Vocational , Work Capacity Evaluation , Workers' Compensation
11.
Int J Rehabil Res ; 8(2): 143-51, 1985.
Article in English | MEDLINE | ID: mdl-2931389

ABSTRACT

Ergonomic work-place design for disabled persons contains the selection of work-places appropriate for disabled, work-place design and work instruction and training. In order to support industry and administration in their activities of designing work-places for disabled workers a taxonomy of technical aids is presented taking into account the information most essential for practitioners. This classification is in accordance with the postulate of the ISO emphasizing the necessity for a classification of aids containing technical work aids as a main group. Therefore the classification system proposed should be considered as a frame work for a general taxonomy of technical aids at all.


Subject(s)
Disabled Persons , Ergonomics , Facility Design and Construction , Humans
12.
Cell Death Differ ; 20(10): 1317-29, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23832115

ABSTRACT

We previously reported that gliotoxin (GT), the major virulence factor of the mold Aspergillus fumigatus causing invasive aspergillosis (IA) in immunocompromised patients, induces apoptosis in a Bak-dependent manner. The signaling pathway leading to Bak activation and subsequent mitochondrial outer membrane permeabilization (MOMP) is elusive. Here, we show that GT and the supernatant of A. fumigatus (but not its GT-defective mutant) activate the JNK pathway and require a co-operative JNK-mediated BimEL phosphorylation at three sites (S100, T112 and S114) to induce apoptosis in mouse fibroblasts, human bronchial and mouse alveolar epithelial cells. Cells (i) treated with the JNK inhibitor SP600125, (ii) deleted or knocked down for JNK1/2 or Bim or (iii) carrying the BimEL triple phosphomutant S100A/T112A/S114A instead of wild-type BimEL are similarly resistant to GT-induced apoptosis. Triple-phosphorylated BimEL is more stable, redistributes from a cytoskeletal to a membrane fraction, better interacts with Bcl-2 and Bcl-xL and more effectively activates Bak than the unphosphorylated mutant. These data indicate that JNK-mediated BimEL phosphorylation at S100, T112 and S114 constitutes a novel regulatory mechanism to activate Bim in response to apoptotic stimuli.


Subject(s)
Apoptosis Regulatory Proteins/metabolism , Apoptosis/drug effects , Gliotoxin/pharmacology , MAP Kinase Kinase 4/metabolism , Membrane Proteins/metabolism , Proto-Oncogene Proteins/metabolism , Animals , Apoptosis Regulatory Proteins/genetics , Aspergillus fumigatus/chemistry , Bcl-2-Like Protein 11 , HEK293 Cells , Humans , MAP Kinase Kinase 4/genetics , Membrane Proteins/genetics , Mice , Phosphorylation , Proto-Oncogene Proteins/genetics , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL